Section Arrow
PRTG.NASDAQ
- Portage Biotech
(Financial Status)
Quotes are at least 15-min delayed:2024/05/17 12:29 EDT
Last
 0.26
-0.007 (-2.62%)
Day High 
0.2705 
Prev. Close
0.267 
1-M High
0.4195 
Volume 
65.73K 
Bid
0.2511
Ask
0.26
Day Low
0.2595 
Open
0.27 
1-M Low
0.1999 
Market Cap 
5.28M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.28 
20-SMA 0.26 
50-SMA 0.4 
52-W High 4.4 
52-W Low 0.1999 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.52/-1.03
Enterprise Value
8.64M
Balance Sheet
Book Value Per Share
1.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.178+0.058+48.33%-- 
SCPXScorpius Holdings0.1128+0.0127+12.69%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
JAGXJaguar Health0.2658-0.0209-7.29%-- 
ONCOOnconetix0.1786+0.0376+26.67%-- 
Quotes are at least 15-min delayed:2024/05/17 12:29 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.